229 related articles for article (PubMed ID: 22249415)
1. BMP signalling controls the malignant potential of ascites-derived human epithelial ovarian cancer spheroids via AKT kinase activation.
Peart TM; Correa RJ; Valdes YR; Dimattia GE; Shepherd TG
Clin Exp Metastasis; 2012 Apr; 29(4):293-313. PubMed ID: 22249415
[TBL] [Abstract][Full Text] [Related]
2. Modulation of AKT activity is associated with reversible dormancy in ascites-derived epithelial ovarian cancer spheroids.
Correa RJ; Peart T; Valdes YR; DiMattia GE; Shepherd TG
Carcinogenesis; 2012 Jan; 33(1):49-58. PubMed ID: 22045027
[TBL] [Abstract][Full Text] [Related]
3. Myxoma virus-mediated oncolysis of ascites-derived human ovarian cancer cells and spheroids is impacted by differential AKT activity.
Correa RJ; Komar M; Tong JG; Sivapragasam M; Rahman MM; McFadden G; Dimattia GE; Shepherd TG
Gynecol Oncol; 2012 May; 125(2):441-50. PubMed ID: 22306204
[TBL] [Abstract][Full Text] [Related]
4. TGFβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids.
Rafehi S; Ramos Valdes Y; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG
Endocr Relat Cancer; 2016 Mar; 23(3):147-59. PubMed ID: 26647384
[TBL] [Abstract][Full Text] [Related]
5. Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions.
Matte I; Legault CM; Garde-Granger P; Laplante C; Bessette P; Rancourt C; Piché A
Clin Exp Metastasis; 2016 Dec; 33(8):839-852. PubMed ID: 27612856
[TBL] [Abstract][Full Text] [Related]
6. Intact LKB1 activity is required for survival of dormant ovarian cancer spheroids.
Peart T; Ramos Valdes Y; Correa RJ; Fazio E; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG
Oncotarget; 2015 Sep; 6(26):22424-38. PubMed ID: 26068970
[TBL] [Abstract][Full Text] [Related]
7. Metastatic Voyage of Ovarian Cancer Cells in Ascites with the Assistance of Various Cellular Components.
Uno K; Iyoshi S; Yoshihara M; Kitami K; Mogi K; Fujimoto H; Sugiyama M; Koya Y; Yamakita Y; Nawa A; Kanayama T; Tomita H; Enomoto A; Kajiyama H
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457198
[TBL] [Abstract][Full Text] [Related]
8. Combination of AKT inhibition with autophagy blockade effectively reduces ascites-derived ovarian cancer cell viability.
Correa RJ; Valdes YR; Peart TM; Fazio EN; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG
Carcinogenesis; 2014 Sep; 35(9):1951-61. PubMed ID: 24562574
[TBL] [Abstract][Full Text] [Related]
9. SMIFH2-mediated mDia formin functional inhibition potentiates chemotherapeutic targeting of human ovarian cancer spheroids.
Ziske MA; Pettee KM; Khaing M; Rubinic K; Eisenmann KM
Biochem Biophys Res Commun; 2016 Mar; 472(1):33-9. PubMed ID: 26898799
[TBL] [Abstract][Full Text] [Related]
10. An mDia2/ROCK signaling axis regulates invasive egress from epithelial ovarian cancer spheroids.
Pettee KM; Dvorak KM; Nestor-Kalinoski AL; Eisenmann KM
PLoS One; 2014; 9(2):e90371. PubMed ID: 24587343
[TBL] [Abstract][Full Text] [Related]
11. Constitutive activation of BMP signalling abrogates experimental metastasis of OVCA429 cells via reduced cell adhesion.
Shepherd TG; Mujoomdar ML; Nachtigal MW
J Ovarian Res; 2010 Feb; 3():5. PubMed ID: 20187934
[TBL] [Abstract][Full Text] [Related]
12. Small molecule inhibitor of the bone morphogenetic protein pathway DMH1 reduces ovarian cancer cell growth.
Hover LD; Young CD; Bhola NE; Wilson AJ; Khabele D; Hong CC; Moses HL; Owens P
Cancer Lett; 2015 Nov; 368(1):79-87. PubMed ID: 26235139
[TBL] [Abstract][Full Text] [Related]
13. Versican regulates metastasis of epithelial ovarian carcinoma cells and spheroids.
Desjardins M; Xie J; Gurler H; Muralidhar GG; Sacks JD; Burdette JE; Barbolina MV
J Ovarian Res; 2014; 7():70. PubMed ID: 24999371
[TBL] [Abstract][Full Text] [Related]
14. Dorsomorphin and LDN-193189 inhibit BMP-mediated Smad, p38 and Akt signalling in C2C12 cells.
Boergermann JH; Kopf J; Yu PB; Knaus P
Int J Biochem Cell Biol; 2010 Nov; 42(11):1802-7. PubMed ID: 20691279
[TBL] [Abstract][Full Text] [Related]
15. SMYD3 promotes implant metastasis of ovarian cancer via H3K4 trimethylation of integrin promoters.
Lyu T; Jiang Y; Jia N; Che X; Li Q; Yu Y; Hua K; Bast RC; Feng W
Int J Cancer; 2020 Mar; 146(6):1553-1567. PubMed ID: 31503345
[TBL] [Abstract][Full Text] [Related]
16. Goserelin promotes the apoptosis of epithelial ovarian cancer cells by upregulating forkhead box O1 through the PI3K/AKT signaling pathway.
Zhang N; Qiu J; Zheng T; Zhang X; Hua K; Zhang Y
Oncol Rep; 2018 Mar; 39(3):1034-1042. PubMed ID: 29286125
[TBL] [Abstract][Full Text] [Related]
17. Re-purposing of curcumin as an anti-metastatic agent for the treatment of epithelial ovarian cancer: in vitro model using cancer stem cell enriched ovarian cancer spheroids.
He M; Wang D; Zou D; Wang C; Lopes-Bastos B; Jiang WG; Chester J; Zhou Q; Cai J
Oncotarget; 2016 Dec; 7(52):86374-86387. PubMed ID: 27863439
[TBL] [Abstract][Full Text] [Related]
18. Enrichment of ovarian cancer stem-like cells is associated with epithelial to mesenchymal transition through an miRNA-activated AKT pathway.
Luo X; Dong Z; Chen Y; Yang L; Lai D
Cell Prolif; 2013 Aug; 46(4):436-46. PubMed ID: 23869765
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Ovarian Cancer Cell Spheroid Formation by Synthetic Peptides Derived from Nectin-4.
Boylan KLM; Manion RD; Shah H; Skubitz KM; Skubitz APN
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32629816
[TBL] [Abstract][Full Text] [Related]
20. Kinase-driven metabolic signalling as a predictor of response to carboplatin-paclitaxel adjuvant treatment in advanced ovarian cancers.
Sereni MI; Baldelli E; Gambara G; Ravaggi A; Hodge KA; Alberts DS; Guillen-Rodriguez JM; Dong T; Memo M; Odicino F; Angioli R; Liotta LA; Pecorelli SL; Petricoin EF; Pierobon M
Br J Cancer; 2017 Aug; 117(4):494-502. PubMed ID: 28664915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
